Heart Failure in Older Adults: The Experts Answer Your Frequently Asked Questions

Download this PDF guide to review expert answers to commonly asked questions on managing patients with heart failure.
person default
Margaret Bowers, DNP, FNP-BC
person default
Gregg C. Fonarow, MD
Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA
Format: Adobe Acrobat (.pdf)
File Size: 126 KB
Released: July 24, 2020

Acknowledgements

Provided by University of Cincinnati, in collaboration with ASCP and GAPNA.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

 

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

 

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Novartis Pharmaceuticals Corporation

Related Content

Clinical Care Options (CCO) and Practicing Clinicians Exchange (PCE) ClinicalThought commentary with answers from expert faculty on frequently asked questions on SDOH in NVAF

Keith C. Ferdinand, MD, FACC, FAHA
Program Director
David S. Kountz, MD Laura Ross, PA-C, CLS
Released: May 26, 2022

Clinical Care Options (CCO): Expert commentary covering new data in HFpEF diagnosis and treatment from ACC 2022 Annual Scientific Sessions

Lee R. Goldberg, MD, MPH, FACC Physicians: maximum of 0.5 AMA PRA Category 1 Credits Released: April 26, 2022 Expired: April 25, 2023

Clinical Care Options (CCO): Expert commentary covering new data in HFrEF management from ACC 2022, including SODIUM-HF, PROMPT-HF, DIAMOND, and EMPULSE

Lee R. Goldberg, MD, MPH, FACC Physicians: maximum of 0.5 AMA PRA Category 1 Credits Released: April 20, 2022 Expired: April 19, 2023

From ACC 2022, exploratory analysis of renal outcomes with sacubitril/valsartan vs valsartan in HFpEF with and without diabetes in PARAGON-HF trial as reported by Clinical Care Options (CCO)

Released: April 6, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings